Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 (UW PIC 330)
This study has been terminated.
(Enrollment too slow.)
University of Washington
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Ann Collier, University of Washington
First received: October 24, 2008
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||October 2013|
|Primary Completion Date:||February 2012 (Final data collection date for primary outcome measure)|